Review of LUMEVOQ® dossier to resume compassionate access program in France is ongoing; in parallel, work continues on the new RECOVER Phase III clinical trial and marketing application to the MHRA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback